Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
Turkey
14823231.7
Filed on 2014-07-09
14823231.7
Filed on 2014-07-09
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
Sweden
14823231.7
Filed on 2014-07-09
14823231.7
Filed on 2014-07-09
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
Poland
14823231.7
Filed on 2014-07-09
14823231.7
Filed on 2014-07-09
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
The Netherlands
14823231.7
Filed on 2014-07-09
14823231.7
Filed on 2014-07-09
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
Italy
14823231.7
Filed on 2014-07-09
14823231.7
Filed on 2014-07-09
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
Greece
14823231.7
Filed on 2014-07-09
14823231.7
Filed on 2014-07-09
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
France
14823231.7
Filed on 2014-07-09
14823231.7
Filed on 2014-07-09
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
Spain
14823231.7
Filed on 2014-07-09
14823231.7
Filed on 2014-07-09
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
Germany
14823231.7
Filed on 2014-07-09
14823231.7
Filed on 2014-07-09